Characteristics, treatment patterns, and clinical outcomes in patients with advanced non-small cell lung cancer harboring EGFR exon 20 insertions-Reference-Cited by-同舟云学术

Characteristics, treatment patterns, and clinical outcomes in patients with advanced non-small cell lung cancer harboring EGFR exon 20 insertions

Published:2023-06-05 Issue:12 Volume:149 Page:10365-10376
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Liao Ying-Ting,Wang Lei-Chi,Sun Ruei-Lin,Yeh Yi-Chen,Huang Hsu-Ching,Shen Chia-I,Tseng Yen-Han,Hsiao Tsu-Hui,Chao Heng-Sheng,Luo Yung-Hung,Chen Yuh-Min,Chiang Chi-Lu

Funder

Taipei Veterans General Hospital

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00432-023-04921-w.pdf

Reference32 articles.

1. Arcila ME, Nafa K, Chaft JE, Rekhtman N, Lau C, Reva BA, Zakowski MF, Kris MG, Ladanyi M (2013) EGFR exon 20 insertion mutations in lung adenocarcinomas: prevalence, molecular heterogeneity, and clinicopathologic characteristics. Mol Cancer Ther 12(2):220–229. https://doi.org/10.1158/1535-7163.Mct-12-0620

2. Bazhenova L, Minchom A, Viteri S, Bauml JM, Ou SI, Gadgeel SM, Trigo JM, Backenroth D, Li T, Londhe A, Mahadevia P, Girard N (2021) Comparative clinical outcomes for patients with advanced NSCLC harboring EGFR exon 20 insertion mutations and common EGFR mutations. Lung Cancer 162:154–161. https://doi.org/10.1016/j.lungcan.2021.10.020

3. Beau-Faller M, Prim N, Ruppert AM, Nanni-Metéllus I, Lacave R, Lacroix L, Escande F, Lizard S, Pretet JL, Rouquette I, de Crémoux P, Solassol J, de Fraipont F, Bièche I, Cayre A, Favre-Guillevin E, Tomasini P, Wislez M, Besse B, Cadranel J (2014) Rare EGFR exon 18 and exon 20 mutations in non-small-cell lung cancer on 10 117 patients: a multicentre observational study by the French ERMETIC-IFCT network. Ann Oncol 25(1):126–131. https://doi.org/10.1093/annonc/mdt418

4. Byeon S, Kim Y, Lim SW, Cho JH, Park S, Lee J, Sun JM, Choi YL, Lee SH, Ahn JS, Park K, Ahn MJ (2019) Clinical outcomes of EGFR exon 20 insertion mutations in advanced non-small cell lung cancer in Korea. Cancer Res Treat 51(2):623–631. https://doi.org/10.4143/crt.2018.151

5. Cai Y, Wang X, Guo Y, Sun C, Xu Y, Qiu S, Ma K (2019) Successful treatment of a lung adenocarcinoma patient with a novel EGFR exon 20-ins mutation with afatinib: a case report. Medicine (Baltimore) 98(1):e13890. https://doi.org/10.1097/md.0000000000013890